Apcotex Industries

Global Export Improvements And Capacity Expansions Will Define Future Success

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

15 Feb 25

Updated

09 Dec 25

Views

18

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-1.5%

7D

0.8%

Loading

1Y

-1.5%

7D

0.8%

You can edit this narrative until Dec 10 11:10 PM. Then, changes will post as Updates.

Author's Valuation

₹56433.8% undervalued

AnalystConsensusTarget Fair Value

Shared on 09 Dec 25

523694: Capacity Expansion At Valia Facility Will Drive Future Earnings Upside

Analysts have reaffirmed their price target for Apcotex Industries at ₹564.00, maintaining prior fair value as they continue to see a balanced outlook driven by steady revenue growth expectations, stable profit margin forecasts and an unchanged view on future valuation multiples. What's in the News Board approves fresh capital expenditure of INR 2,100 million to expand capacity at the Valia, Gujarat manufacturing facility, targeting higher domestic and export sales (company filing) Planned capacity addition includes 37,000 MTPA of Synthetic Latex and 14,600 MTPA of Nitrile Rubber and allied products, to be commissioned in phases by the first quarter of FY27 (company filing) Upcoming board meeting on November 5, 2025, will review audited financial results for the quarter and half year ended September 30, 2025, and formalize the capacity expansion plan (company notice) Valuation Changes Fair Value: Unchanged at ₹564.00 per share, indicating no revision in the intrinsic value estimate.

Shared on 25 Nov 25

Fair value Increased 15%

523694: Capacity Expansion At Valia Facility Will Drive Sales Momentum

Analysts have raised their price target for Apcotex Industries from ₹490 to ₹564. They cite improved revenue growth forecasts, even though the outlook for profit margins is slightly lower.

Shared on 04 Aug 25

Fair value Increased 25%

The upward revision in Apcotex Industries’ consensus price target reflects improved profitability, as evidenced by a higher net profit margin, and a modestly higher anticipated valuation, with the fair value increasing from ₹391.50 to ₹437.50. What's in the News Mr. Vivek Thakur appointed as Chief Financial Officer, bringing over 24 years' experience, including significant leadership roles in the chemicals sector.

Shared on 01 May 25

Fair value Decreased 1.84%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 2.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 13 Mar 25

Fair value Decreased 0.91%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

₹564

33.8% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

16.63%

Chemicals revenue growth rate

0.60%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

13.53%

Calculation

₹1.46b

Earnings '28

x

28.90x

PE Ratio '28

=

₹42.07b

Market Cap '28

₹42.07b

Market Cap '28

/

51.89m

No. shares '28

=

₹810.76

Share Price '28

₹810.76 Share Price '28

Discounted to 2025 @ 13.51% p.a.

=

₹554.28

Fair Value '25